home / stock / rxrx / rxrx quote
Last: | $8.34 |
---|---|
Change Percent: | 0.9% |
Open: | $7.75 |
Close: | $8.34 |
High: | $8.75 |
Low: | $7.73 |
Volume: | 5,733,175 |
Last Trade Date Time: | 05/01/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$8.34 | $7.75 | $8.34 | $8.75 | $7.73 | 5,733,175 | 05-01-2024 |
$7.82 | $8.06 | $7.82 | $8.2625 | $7.8 | 3,849,743 | 04-30-2024 |
$8.2 | $8.3 | $8.2 | $8.545 | $8.09 | 4,108,531 | 04-29-2024 |
$8.12 | $7.86 | $8.12 | $8.1391 | $7.68 | 4,394,004 | 04-26-2024 |
$7.84 | $7.57 | $7.84 | $7.885 | $7.48 | 4,382,391 | 04-25-2024 |
$7.94 | $8.15 | $7.94 | $8.27 | $7.89 | 7,066,017 | 04-24-2024 |
$7.7 | $7.56 | $7.7 | $7.92 | $7.55 | 4,685,194 | 04-23-2024 |
$7.6 | $7.46 | $7.6 | $7.79 | $7.205 | 3,946,342 | 04-22-2024 |
$7.35 | $7.3 | $7.35 | $7.44 | $7.135 | 4,013,543 | 04-19-2024 |
$7.4 | $7.35 | $7.4 | $7.58 | $7.27 | 2,862,410 | 04-18-2024 |
$7.47 | $7.64 | $7.47 | $7.71 | $7.43 | 3,507,716 | 04-17-2024 |
$7.57 | $7.61 | $7.57 | $7.77 | $7.51 | 3,847,816 | 04-16-2024 |
$7.79 | $8.41 | $7.79 | $8.4583 | $7.77 | 5,149,258 | 04-15-2024 |
$8.41 | $8.8 | $8.41 | $8.925 | $8.315 | 3,428,259 | 04-12-2024 |
$8.92 | $8.65 | $8.92 | $8.94 | $8.5 | 3,148,604 | 04-11-2024 |
$8.58 | $8.61 | $8.58 | $8.778 | $8.41 | 3,752,477 | 04-10-2024 |
$9.09 | $9 | $9.09 | $9.22 | $8.95 | 2,596,372 | 04-09-2024 |
$9 | $8.91 | $9 | $9.12 | $8.79 | 3,129,444 | 04-08-2024 |
$8.87 | $8.534 | $8.87 | $8.94 | $8.41 | 3,413,361 | 04-05-2024 |
$8.73 | $9.02 | $8.73 | $9.33 | $8.71 | 4,723,884 | 04-04-2024 |
News, Short Squeeze, Breakout and More Instantly...
Recursion Pharmaceuticals Inc. Company Name:
RXRX Stock Symbol:
NASDAQ Market:
SALT LAKE CITY, April 30, 2024 (GLOBE NEWSWIRE) -- Altitude Lab and the Small Business Administration (SBA) are pleased to announce Horizon , a commercialization program to connect startups to distributors, biopharma partners, and strategic investors in major biotech hubs nationwide, providin...
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended selling Petróleo Brasileiro S.A. – Petrobras (NYSE:PBR)...